Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091823
Filing Date
2024-08-06
Accepted
2024-08-06 16:13:30
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20240630.htm   iXBRL 10-Q 1700148
2 EX-31.1 idya-ex31_1.htm EX-31.1 15385
3 EX-31.2 idya-ex31_2.htm EX-31.2 15050
4 EX-32.1 idya-ex32_1.htm EX-32.1 12436
  Complete submission text file 0000950170-24-091823.txt   7254787

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20240630.xsd EX-101.SCH 1158966
66 EXTRACTED XBRL INSTANCE DOCUMENT idya-20240630_htm.xml XML 1087518
Mailing Address 7000 SHORELINE CT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE CT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 241179401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)